Patients with inflammatory bowel disease (IBD) are at increased risk of thrombotic events.
Therapies for IBD have the potential to modulate this risk. The aims of this Evidence-Based …

This review discussed and in particular emphasis the potential cellular pathways and the
biological processes involved that lead to homocysteine-induced endothelial dysfunction, in …

Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of
hospitalization for major surgery (or associated with the late stage of terminal illness) …

The risk factors for venous thrombosis differ from those for arterial vascular disease. During
the past 5 years, knowledge about the aetiology of venous thrombosis has advanced with …

According to a recent hypothesis, venous thrombosis results from the concurrence of several
factors. This hypothesis was assessed in patients with portal or hepatic venous thrombosis …

Background: There is an impression mostly from specialty clinics that patients with
inflammatory bowel disease (IBD) have an increased risk of venous thromboembolic …

Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome
are some of the most common disorders. A thrombus either arises spontaneously or is …

Venous thrombosis occurs in about 1 per 1,000 individuals per year. 1, 2 It usually affects
the deep veins of the leg, but may occur in other sites, such as the upper extremities …

Context: It has been suggested that elevated total plasma homocysteine levels are
associated with the risk of venous thrombosis. Objective: To assess the relationship of …

Background: Obesity is known to be a multifactorial disease. In its pathogenesis, different
factors such as chronic inflammation, oxidative stress, insulin resistance, genetic factors …